Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -128,659 | -53,333 | -247,116 | -175,575 | -133,055 |
| Depreciation Amortization | -3,405 | -980 | -340 | 223 | 564 |
| Accounts receivable | -6,968 | 2,019 | -21,470 | -13,827 | -12,343 |
| Other Working Capital | -34,302 | -27,658 | -58,945 | -47,187 | -29,259 |
| Other Operating Activity | 107,008 | 32,440 | 166,021 | 98,365 | 68,536 |
| Operating Cash Flow | $-66,326 | $-47,512 | $-161,850 | $-138,001 | $-105,557 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -125,517 | -106,949 | -126,887 | -204,628 | -135,260 |
| PPE Investments | -627 | -160 | -1,351 | -825 | -650 |
| Investing Cash Flow | $-126,144 | $-107,109 | $-128,238 | $-205,453 | $-135,910 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 300,000 | N/A | 73,072 | 73,072 | N/A |
| Debt Repayment | -261,713 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,031 | 5,077 | 14,955 | 10,756 | 7,503 |
| Other Financing Activity | -10,885 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $34,433 | $5,077 | $88,027 | $83,828 | $7,503 |
| Exchange Rate Effect | -413 | -96 | 566 | 235 | 249 |
| Beginning Cash Position | 306,239 | 306,239 | 507,734 | 507,734 | 507,734 |
| End Cash Position | 147,789 | 156,599 | 306,239 | 248,343 | 274,019 |
| Net Cash Flow | $-158,450 | $-149,640 | $-201,495 | $-259,391 | $-233,715 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,326 | -47,512 | -161,850 | -138,001 | -105,557 |
| Capital Expenditure | -627 | -160 | -1,351 | -825 | -650 |
| Free Cash Flow | -66,953 | -47,672 | -163,201 | -138,826 | -106,207 |